Treg Summit 2018 - Treg Directed Therapy for Autoimmune Disorders

Treg Summit 2018 - Treg Directed Therapy for Autoimmune Disorders is organized by Hanson Wade and will be held during May 22 - 24, 2018 at The Westin Boston Waterfront, Boston, Massachusetts, United States of America.

The Treg Summit is your first and only opportunity to join the leading experts in the Autoimmune Community in their fight to create a targeted therapeutic approach to treat autoimmune disorders. Listen to the most advanced clinical case studies alongside innovative research methods to accelerate your autoimmune pipeline to clinical development.

Join us in exploring the main challenges facing Treg directed therapies including strategies to identify and target autoantigens as well as creating Treg cells that remain stable and persistent in the body. Take this time to work with the greatest minds in the field to create forward thinking strategies to develop targeted and effective Treg directed therapies.

Why you should attend?
• Stable - Evaluate feasible methods to promote Treg stability to prevent their inherent ability to switch to pathogenic cells.
• Persistent - Join the discussion exploring methods that promote Treg persistence with our panel experts from Merck, Vedanta Bioscience, Immune Tolerance Network & Cellenkos.
• Targeted - Listen to presentations from Casebia and TxCell to ensure a precise targeting approach for your Treg therapeutic with the use of CARs and TCRs.

Additional details will be posted as soon as they are available.